Statistics for Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy
Total visits
| views | |
|---|---|
| Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy | 78 |
Total visits per month
| views | |
|---|---|
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
File Visits
| views | |
|---|---|
| Trial design and rationalefor APOLLO.pdf(legacy) | 103 |
| Trial design and rationalefor APOLLO.pdf | 7 |
Top country views
| views | |
|---|---|
| United States | 30 |
| China | 27 |
| Russia | 10 |
| Portugal | 4 |
| India | 2 |
| Germany | 1 |
| United Kingdom | 1 |
| Ireland | 1 |
| Panama | 1 |
| Poland | 1 |
| Singapore | 1 |
Top city views
| views | |
|---|---|
| Bengaluru | 1 |